Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Quaterly
Nectar Lifesciences Ltd.
BSE Code 532649
ISIN Demat INE023H01027
Book Value (Rs) 42.63
NSE Code NECLIFE
Dividend Yield % 0.00
Market Cap(Rs Mn) 4507.65
TTM PE(x) 0.00
TTM EPS(Rs) -5.07
Face Value (Rs) 1  
Type: Quarters :
(Rs. in Million)
Particulars(Rs in Millions)Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Audited / UnAudited UnAudited UnAudited UnAudited UnAudited UnAudited
 Net Sales 4306.95 4549.82 4280.98 3593.00 4413.75
 Total Expenditure 5849.98 4102.72 3847.65 3194.97 3928.70
 PBIDT (Excl OI) -1543.03 447.10 433.33 398.03 485.05
 Other Income 0.78 5.73 6.89 5.51 14.68
 Operating Profit -1542.26 452.83 440.22 403.54 499.73
 Interest 176.72 171.22 198.08 199.77 241.60
 Exceptional Items 0 0 0 0 0
 PBDT -1718.98 281.61 242.14 203.77 258.13
 Depreciation 157.67 156.14 155.49 154.60 147.00
 Profit Before Tax -1876.65 125.47 86.65 49.17 111.13
 Tax -575.76 47.07 30.67 19.48 105.20
 Provisions and contingencies 0 0 0 0 0
 Profit After Tax -1300.89 78.40 55.98 29.69 5.93
  Extraordinary Items 0 0 0 0 0
  Prior Period Expenses 0 0 0 0 0
  Other Adjustments 0 0 0 0 0
 Net Profit -1300.89 78.40 55.98 29.69 5.93
 Minority Interest 0 0 0 0 0
 Shares of Associates     
 Other related items     
 Misc. Expenses Written off 0 0 0 0 0
 Consolidated Net Profit -1300.89 78.40 55.99 29.69 5.92
 Equity Capital 224.26 224.26 224.26 224.26 224.26
 Face Value (IN RS) 1.00 1.00 1.00 1.00 1.00
 Reserves 0 0 0 0 0
 Calculated EPS -5.80 0.35 0.25 0.13 0.03
 Calculated EPS (Annualised) -23.20 1.40 1.00 0.53 0.11
 No of Public Share Holdings 124392970.00 124392970.00 78792970.00 78792970.00 78792970.00
 % of Public Share Holdings 55.47 55.47 44.20 44.20 44.20
       
 PBIDTM% (Excl OI) -35.83 9.83 10.12 11.08 10.99
 PBIDTM% -35.81 9.95 10.28 11.23 11.32
 PBDTM% -39.91 6.19 5.66 5.67 5.85
 PBTM% -43.57 2.76 2.02 1.37 2.52
 PATM% -30.20 1.72 1.31 0.83 0.13
  Notes Notes Notes Notes Notes